101 related articles for article (PubMed ID: 73485)
1. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
Petricciani JC; Milstien JB
Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
[TBL] [Abstract][Full Text] [Related]
2. [Production of oncornaviruses by cell cultures].
Lozinskiĭ TF; Volkova MIa; Abenova UA; Mazurenko NN; Miller GG
Vopr Onkol; 1974; 20(1):56-62. PubMed ID: 4140609
[No Abstract] [Full Text] [Related]
3. The contribution of cytochemistry and electron microscopy to the detection of contaminants in the cell material used for the production of virus vaccines.
Rau C; Palade V; Voiculescu C; Samoilescu M
Dev Biol Stand; 1976 Dec 13-15; 37():245-8. PubMed ID: 201521
[TBL] [Abstract][Full Text] [Related]
4. Primate endogenous viruses: their role in oncogenesis and as biohazards.
Kalter SS; Heberling RL
Dev Biol Stand; 1976 Dec 13-15; 37():219-28. PubMed ID: 829599
[No Abstract] [Full Text] [Related]
5. Reverse transcriptase and thymidine kinase as markers for tumorigenicity and viral contamination of cells.
Garrett AJ; Swindells D
Dev Biol Stand; 1976 Dec 13-15; 37():205-10. PubMed ID: 73484
[TBL] [Abstract][Full Text] [Related]
6. Replication of primate oncornavirus SSV-1 on MRC-5 human diploid cells.
Horodniceanu F; Sinoussi F; Chermann JC; Tardy-Panit M; Michelson-Fiske S; Yvert F
Dev Biol Stand; 1976 Dec 13-15; 37():201-4. PubMed ID: 73483
[TBL] [Abstract][Full Text] [Related]
7. RNA tumor virus and reverse transcriptase. I. Biochemical studies on the ESP-1 particles. II. Role of the reverse transcriptase in murine RNA tumor virus.
Wu AM; Ting RC; Yang SS; Gallo RC; Paran M
Bibl Haematol; 1973; 39():506-17. PubMed ID: 4130399
[No Abstract] [Full Text] [Related]
8. Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines.
André M; Morgeaux S; Fuchs F
Biologicals; 2000 Jun; 28(2):67-80. PubMed ID: 10885614
[TBL] [Abstract][Full Text] [Related]
9. Safety of viral vaccine cell substrates: a reevaluation.
Petricciani JC; Milstien JB; Seifried AS; Wallace RE; Johnson JB; McCoy DW
J Natl Cancer Inst; 1976 Oct; 57(4):915-9. PubMed ID: 63564
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus screening of vaccine cell substrates.
Khan AS
Dev Biol Stand; 1996; 88():157-62. PubMed ID: 9119131
[TBL] [Abstract][Full Text] [Related]
11. The significance of positive controls in testing the oncogenic potential of cell material for virus vaccine production.
Rau C; Voiculescu C; Palade V
Dev Biol Stand; 1976 Dec 13-15; 37():241-4. PubMed ID: 1031687
[TBL] [Abstract][Full Text] [Related]
12. A comparison of methods for the estimation of retroviral burden.
Bierley ST; Raineri R; Poiley JA; Morgan EM
Dev Biol Stand; 1996; 88():163-5. PubMed ID: 9119132
[TBL] [Abstract][Full Text] [Related]
13. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity.
Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ
J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture.
Brorson K; Xu Y; Swann PG; Hamilton E; Mustafa M; de Wit C; Norling LA; Stein KE
Biologicals; 2002 Mar; 30(1):15-26. PubMed ID: 11846426
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.
Audet SA; Crim RL; Beeler J
Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055
[TBL] [Abstract][Full Text] [Related]
16. [Morphogenesis and structure of RNA tumor viruses. Electron microscopy studies on C-type viruses].
Gelderblom H; Bauer H; Bolognesi DP; Frank H
Zentralbl Bakteriol Orig A; 1972 May; 220(1):79-90. PubMed ID: 4122879
[No Abstract] [Full Text] [Related]
17. Replacement of animals in manufacture and control of vaccines.
Hennessen W
Dev Biol Stand; 1980; 45():163-73. PubMed ID: 6772505
[TBL] [Abstract][Full Text] [Related]
18. Issues of biological assays for viral vaccines.
Lee CK
Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
[TBL] [Abstract][Full Text] [Related]
19. Molecular methods for virus discovery.
Jarrett RF; Johnson D; Wilson KS; Gallagher A
Dev Biol (Basel); 2006; 123():77-88; discussion 119-32. PubMed ID: 16566437
[TBL] [Abstract][Full Text] [Related]
20. Bovine viral diarrhea virus contamination of nutrient serum, cell cultures and viral vaccines.
Levings RL; Wessman SJ
Dev Biol Stand; 1991; 75():177-81. PubMed ID: 1665461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
